Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149958 (
complex partial seizures
)
2,563
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum prolactin (
HPR
) levels are influenced by waking and sleep states, as reflected by surges in serum concentrations during daytime naps and nocturnal sleep. Other physiological causes of hyperprolactinemia include sexual activity, pregnancy, and lactation. Drugs may stimulate or inhibit
HPR
secretion. Pathological causes for
HPR
secretion include destructive lesions of the hypothalamus, prolactin-secreting neoplasms of the pituitary gland, lesions of the spinal cord, and occasionally Parkinson's disease. The most predictable postictal changes are increased serum cortisol levels and hyperprolactinemia. Serum
HPR
rises after virtually all generalized tonic-clonic seizures, most
complex partial seizures
, and some simple partial seizures. Absence and myoclonic seizures do not affect serum
HPR
levels. Repeated epileptic seizures and electroconvulsive therapy treatments produce successively less marked rises in serum
HPR
. The postictal elevation of serum cortisol has a longer latency than for
HPR
and follows an earlier rise in serum ACTH. Other postictal hormonal changes are much more variable. Because of the normal diurnal variation in serum cortisol levels and the relative delay in the postictal elevation of serum cortisol,
HPR
is more useful as a diagnostic measure of epileptic seizures. This application of
HPR
requires an understanding of other factors that influence serum
HPR
and the use of baseline serum
HPR
levels for comparison.
HPR
data must be correlated with behavioral and electroencephalographic events.
...
PMID:The effect of seizures on hormones. 165 82